News Conference News CRT 2026 Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR Michael O'Riordan March 11, 2026
News Conference News CRT 2026 DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients L.A. McKeown March 09, 2026